Protein C system in preterm babies with chronic lung disease: Prospective study. Issue 1 (1st August 2022)

• Record Type: Journal Article
• Authors: Kamamoto, Tomoyuki; Nakajima, Yuto; Uchida, Yumiko; Nakagawa, Takashi; Tonegawa, Hitoshi; Tani, Yuki; Nishimoto, Eri; Takahashi, Yukihiro; Nishikubo, Toshiya; Nogami, Keiji
• Is Part Of: Pediatrics international. Volume 64:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-08-01
• Subjects: anticoagulant factor -- inflammation -- mechanical ventilation -- thrombomodulin -- very low birth weight infants; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/ped.15221
• Languages: English
• ISSNs: 1328-8067

Abstract

Abstract: Background: Chronic lung disease (CLD) is a major neonatal pulmonary disorder associated with inflammation. Recent studies have shown that protein C anticoagulant pathways, such as those for protein C (PC), protein S (PS), and thrombomodulin (TM), could be useful indices for reflecting pulmonary injury. However, the involvement of these factors in preterm infants with very low birthweight (VLBW) who have developed CLD remains to be investigated. Here, we investigated whether PC pathway‐related factors could predict the development of CLD in preterm infants with VLBW. Methods: We collected plasma samples from 26 preterm infants with VLBW (13 each from those with and without CLD) at the time of birth and measured TM, PC, and PS levels in their plasmas. We analyzed prospectively the relationship between these factors in infants with and without CLD. Results: There were significant differences in gestational age, birthweight, Apgar score (5 min), and duration of mechanical ventilation between the CLD and non‐CLD groups. No significant differences in the PC and PS levels at birth were observed between the two groups, whereas the TM levels in the CLD group were significantly higher than those in the non‐CLD group ( P = 0.013). The TM levels correlated with gestational age and duration of mechanical ventilation. However, covariance analysis demonstrated that gestational age was significantly associated with TM levels, and consequently, development of CLD was not associated with TM level at birth. Conclusions: Thrombomodulin, PC, and PS levels at birth could not predict the development of CLD in preterm infants with VLBW.